Linda Xu

Most-cited papers

1. Self-reactive IgE exacerbates interferon responses associated with autoimmunity

   J. Hénault, J. Riggs, J. Karnell, Vladimir M. Liarski +15 more

   2015Nature Immunology154 citations Open access

   Semantic Scholar

   Save

2. A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.

   D. Jackson, J. Gooya, Shen-Lan Mao, Krista Kinneer +13 more

   2008Cancer Research140 citations Open access

   Semantic Scholar

   Save

3. Abatacept binds to the Fc receptor CD64 but does not mediate complement-dependent cytotoxicity or antibody-dependent cellular cytotoxicity.

   P. M. Davis, R. Abraham, Linda Xu, S. Nadler +1 more

   2007Journal of Rheumatology98 citations

   Semantic Scholar

   Save

4. Complement C5a potentiates uric acid crystal‐induced IL‐1β production

   L. An, Payal Mehta, Linda Xu, S. Turman +6 more

   2014European Journal of Immunology77 citations Open access

   Semantic Scholar

   Save

5. Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody

   V. Oganesyan, Li Peng, Jared S. Bee, John Y Li +11 more

   2018Journal of Biological Chemistry58 citations Open access

   Semantic Scholar

   Save

6. Abstract 30: Medi3622, a monoclonal antibody to ADAM17, inhibits tumor growth by inhibiting EGFR- and non-EGFR-mediated pathways

   Darrin Sabol, J. Rios-Doria, Jon Chesebrough, David Stewart +23 more

   201541 citations

   Semantic Scholar

   Save

7. Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine-Conjugated Antibody–Drug Conjugate Targeting 5T4

   Jay Harper, Christopher Lloyd, N. Dimasi, D. Toader +26 more

   2017Molecular Cancer Therapeutics36 citations

   Semantic Scholar

   Save

8. Molecular basis for the mechanism of action of an anti-TACE antibody

   Li Peng, Kimberly E. Cook, Linda Xu, Li Cheng +4 more

   2016mAbs30 citations Open access

   Semantic Scholar

   Save

9. Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific Antibody

   S. Kasturirangan, G. Rainey, Linda Xu, Xin-Wei Wang +9 more

   2017Journal of Biological Chemistry29 citations Open access

   Semantic Scholar

   Save

10. Development of a Trispecific Antibody Designed to Simultaneously and Efficiently Target Three Different Antigens on Tumor Cells.

    N. Dimasi, Ryan L. Fleming, Carl M. Hay, Robert M. Woods +3 more

    2015Molecular Pharmaceutics21 citations

    Semantic Scholar

    Save

11. A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non–EGFR-Mediated Pathways

    J. Rios-Doria, Darrin Sabol, Jon Chesebrough, David Stewart +17 more

    2015Molecular Cancer Therapeutics17 citations Open access

    Semantic Scholar

    Save

12. Redirecting the specificity of tripartite motif containing-21 scaffolds using a novel discovery and design approach

    Derek VanDyke, Linda Xu, Paul R. Sargunas, R. Gilbreth +4 more

    2023Journal of Biological Chemistry9 citations Open access

    Semantic Scholar

    Save

13. A mammalian expression system for high throughput antibody screening.

    Linda Xu, Xiao-Fang Jin, G. Rainey, Herren Wu +1 more

    2013JIM - Journal of Immunological Methods6 citations

    Semantic Scholar

    Save

14. Human Relaxin-2 Fusion for the Treatment of Heart Failure

    Wei-Dong Hao, Andrew Garcia, Vanessa M. Muniz-Medina, A. Sadowska +14 more

    2018Journal of Molecular and Cellular Cardiology0 citations

    Semantic Scholar

    Save

15. Targeting different isoforms of HMGB1 leads to different beneficial effects in preclinical models of sepsis and inflammatory arthritis (100.6)

    L. An, Linda Xu, Arnita Sunhe Barber, Shen-Lan Mao +8 more

    2007Journal of Immunology0 citations

    Semantic Scholar

    Save